InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,833.51
(
0.06%
)
Post# of 2795
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

longx

Send PM Follow Ignore
Followers 14
Posts 396
Boards Moderated 0
Alias Born 12/18/2014

longx

Re: longx post# 2780

Monday, 08/12/2019 3:15:11 PM

Monday, August 12, 2019 3:15:11 PM

Post# of 2795
According to today news release (see the link below)
The first milestone payment of $0.34/share will be by the end of this year: "...The company expects to begin recruiting by the end of 2019 for a Phase 3 clinical trial investigating MNK-6105 in patients being treated for acute HE in the hospital."

And once phase 2a of MNK-6106 to be completed by the end of Q1/2020, if the results is good, phase 3 should follow after that and we will receive the 2nd milestone payment in Q2/2020.

https://finance.yahoo.com/news/first-patient-enrolled-mallinckrodts-phase-104500633.html
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up